GLRX and pulmonary fibrosis: A more detailed mechanistic analysis using a transgenic Grx-/- mouse model showed that the induction of lung fibrosis generated substantially higher PSSG that could be reversed by exogenous administration of recombinant Grx1, thus opening a new therapeutic approach for lung fibrosis.